Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD)
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02959944. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind Phase 3 Study of Ibrutinib in Combination With Corticosteroids Versus Placebo in Combination With Corticosteroids in Subjects With New Onset Chronic Graft Versus Host Disease (cGVHD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the safety and efficacy of ibrutinib in combination with prednisone in subjects with newly diagnosed moderate to severe cGVHD.
Study identification
- NCT ID
- NCT02959944
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 193 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 11, 2017 (Actual)
- Primary completion
- Mar 27, 2020 (Actual)
- Completion
- Jul 12, 2021 (Actual)
- Last update posted
- Mar 30, 2023
2017 – 2021
United States locations
- U.S. sites
- 38
- U.S. states
- 23
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Oncology - Scottsdale - Cancer Transplant Institute Location /ID# 1140-1120 | Scottsdale | Arizona | 85258-4547 | — |
| LPCH Stanford /ID# 1140-1128 | Palo Alto | California | 94304 | — |
| Ucsf /Id# 1140-0003 | San Francisco | California | 94143 | — |
| Stanford University/Stanford Cancer Center, Pasteur Drive /ID# 1140-0400 | Stanford | California | 94305 | — |
| UCHSC Anschultz Cancer Pavilion /ID# 1140-0068 | Aurora | Colorado | 80010 | — |
| Children's National Medical Center /ID# 1140-1122 | Washington D.C. | District of Columbia | 20010 | — |
| Jackson Memorial Hospital, University of Miami /ID# 1140-0647 | Miami | Florida | 33136-1096 | — |
| Florida Hospital Cancer Institute/Adventist Health System/Sunbelt, Inc /ID# 1140-1121 | Orlando | Florida | 32804 | — |
| Emory University, Winship Cancer Institute /ID# 1140-0033 | Atlanta | Georgia | 30322 | — |
| Emory University/Winship Cancer Institute /ID# 1140-1179 | Atlanta | Georgia | 30322 | — |
| University of Chicago /ID# 1140-0126 | Chicago | Illinois | 60637 | — |
| Loyola University /ID# 1140-0713 | Maywood | Illinois | 60153 | — |
| Indiana University Melvin and Bren Simon Cancer Center /ID# 1140-0010 | Indianapolis | Indiana | 46202-5112 | — |
| University of Kentucky /ID# 1140-1140 | Lexington | Kentucky | 40508-2678 | — |
| University of Louisville Hospital /ID# 1140-1131 | Louisville | Kentucky | 40202 | — |
| University of Maryland /ID# 1140-0205 | Baltimore | Maryland | 21201 | — |
| Massachusetts General Hospital Cancer Center /ID# 1140-0020 | Boston | Massachusetts | 02114 | — |
| Boston Childrens Hospital /ID# 1140-1615 | Boston | Massachusetts | 02115 | — |
| Dana-Farber Cancer Institute /ID# 1140-0349 | Boston | Massachusetts | 02215 | — |
| Barbara Ann Karmanos Cancer In /ID# 1140-0130 | Detroit | Michigan | 48201 | — |
| University of Minnesota /ID# 1140-0807 | Minneapolis | Minnesota | 55455 | — |
| Mayo Clinic, Rochester, MN /ID# 1140-0240 | Rochester | Minnesota | 55905 | — |
| Hackensack University Medical Center/ John Theurer Cancer Center /ID# 1140-0343 | Hackensack | New Jersey | 07601 | — |
| Rutgers Cancer Institute of NJ /ID# 1140-0803 | New Brunswick | New Jersey | 08903 | — |
| New York Presbyterian Hospital/Weill Cornell Med College /ID# 1140-0200 | New York | New York | 10021 | — |
| Stony Brook University Medical Center /ID# 1140-0719 | New York | New York | 10021 | — |
| Columbia University Medical Center, MS-CHONY /ID# 1140-1124 | New York | New York | 10032-1559 | — |
| Weill Cornell Physicians - Hematologic Malignancies & Bone Marrow Transplant /ID# 1140-0019 | New York | New York | 10065 | — |
| University of Rochester Cancer Center /ID# 1140-0127 | Rochester | New York | 14642-0001 | — |
| Montefiore Medical Center - Moses Campus /ID# 1140-0120 | The Bronx | New York | 10467 | — |
| University of North Carolina - Lineberger Comprehensive Cancer Center /ID# 1140-1133 | Chapel Hill | North Carolina | 27516 | — |
| Univ Hosp Cleveland /ID# 1140-0941 | Cleveland | Ohio | 44106 | — |
| University of Pittsburgh - UPMC (Hillman Cancer Center) /ID# 1140-0050 | Pittsburgh | Pennsylvania | 15232 | — |
| Medical University of South Carolina, MUSC /ID# 1140-0738 | Charleston | South Carolina | 29425 | — |
| Vanderbilt University Medical Center Vanderbilt Ingram Cancer Center /ID# 1140-0024 | Nashville | Tennessee | 37232-5280 | — |
| Methodist San Antonio /ID# 1140-1118 | San Antonio | Texas | 78229-3710 | — |
| Fred Hutchinson Cancer Research Center /ID# 1140-0404 | Seattle | Washington | 98109 | — |
| West Virginia University /ID# 1140-1090 | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 64 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02959944, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 30, 2023 · Synced Nov 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.